Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0118
BRL/USD 0,1941
0,0001
INR/USD 0,0104
CNY/USD 0,1488
0,0002
ZAR/USD 0,0613
0,0002
IDR/USD 0,0001
SPACE FOR MEDIA DIPLOMACY
15:00 «BRICSreport»
15:00 «BRICSreport»
Now 16+
15:00

«BRICSreport»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
15:15 «BRICSterview»
Next
15:15

«BRICSterview»

16+
15:30

«Laboratorium»

16+
15:45

Documentary film «Yazd. Iran»

16+
Menu
Broadcast «BRICSreport»
RUB/USD
0,0118
BRL/USD
0,1941
0,0001
INR/USD
0,0104
CNY/USD
0,1488
0,0002
ZAR/USD
0,0613
0,0002
IDR/USD
0,0001
TV BRICS Apps

Indian scientists develop breakthrough nanoformulation for safer Parkinson’s treatment

This innovative nanoformulation prevents mitochondrial damage by inhibiting the translocation of calpain

Indian researchers have unveiled a groundbreaking nanoformulation designed to enhance the safety and effectiveness of Parkinson’s disease treatment. This is reported by IANS, a partner of TV BRICS.

The group of scientists has developed a targeted drug delivery system that enables the sustained release of 17β-oestradiol (E2), a hormone essential for managing Parkinson’s symptoms.

Parkinson’s disease, a progressive neurodegenerative disorder, is linked to an imbalance of 17β-oestradiol in the brain. However, the widespread use of this hormone in therapy has been limited due to its potential side effects and an incomplete understanding of its molecular mechanisms. To address these challenges, researchers have utilised dopamine receptor D3 (DRD3)-conjugated chitosan nanoparticles to precisely deliver 17β-oestradiol to the brain, significantly improving its therapeutic potential.

This innovative nanoformulation prevents mitochondrial damage by inhibiting the translocation of calpain.

The study further revealed a breakthrough in understanding the role of BMI1, a key regulator of mitochondrial homeostasis, in Parkinson’s disease, the source claims. The nanoformulation successfully restored BMI1 expression by preventing its degradation through calpain inhibition, highlighting a new potential target for neuroprotective therapies.

Photo: iStock